Abstract:To describe patterns of out-field regional recurrence after in-field irradiation (IFI) in definitive concurrent chemoradiation therapy (CCRT) for locally advanced esophageal squamous cell carcinoma (LA-ESCC) and identify possible risk factors. Eighty patients with LA-ESCC who received CCRT with IFI between January 2003 and January 2010 in our institution were recruited and analyzed. Imaging scans demonstrating first sites of failure were compared with original computed tomography-based radiation treatment plans, and failure patterns were defined as in-field, out-field regional (failures in initially uninvolved regional nodes), and distant failure. After a median follow-up time of 52.6 months, 24 patients had evidence of out-field regional failure, 43 of in-field failure and 33 of distant failure. Multivariate analysis revealed that out-field regional failure was associated with clinical tumor status (T4 vs. T1-3, odds ratio [OR] =6.547, P= 0.002), tumor length >8 cm vs. ≤8 cm, OR= 2.646, P = 0.035), response to CCRT (complete response vs. no complete response, OR = 2.646, P = 0.035) and in-field failure (no in-field failure vs. in-field failure, OR = 1.32, P = 0.016). Survival analyses indicated that, compared with in-field or distant failure alone group, out-field regional failure alone group tended to have longer overall survival (P = 0.006) and progression free survival (P = 0.164). Our data suggested that LA-ESCC patients with clinical T4 stage, longer lesion, no complete response to CCRT and no in-field failure after treatment were at higher risk for out-field regional failure. In addition, out-field regional failure was likely to appear later than in-field and distant failure. Further prospective studies are needed to verify the findings of current study.

Risk Factors for Out-Field Regional Recurrence after Involved Field Irradiation with Concurrent Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma